ClearPoint Neuro (CLPT) Live Share Price, Invest From India

ClearPoint Neuro Stock Performance

as on October 24, 2026 at 6:24 am IST

Day's Low
Day's High
$8.95
Day's Price Range
$9.14
$9.11
1.76%
Downside
0.33%
Upside
52 Week's Low
52 Week's High
$8.27
52-Week Price Range
$27.27
$9.11
9.22%
Downside
199.34%
Upside

ClearPoint Neuro share price movements today

Previous Close: $9.25
Open: $9.10
Volume: 346.9K
Market Cap: $282.2M
Day's Low - High: $8.95 - $9.14
52 Week Low - High: $8.27 - $27.27

ClearPoint Neuro Historical Returns

1 Month Return: -38.21 %
3 Month Return: -36.16 %
1 Year Return: -63.4 %
3 Year Return: + 95.15 %
5 Year Return: -47.41 %

ClearPoint Neuro Stock Fundamentals & Key Indicators

Check ClearPoint Neuro market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$282.2M

EPS (TTM)

-1.18

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.84

Industry PE ratio

-7.43

PEG Ratio

0.23

EBITDA

-27.1M

Revenue (TTM)

42.3M

Profit Margin

62.61%

Return On Equity TTM

-188.09%

ClearPoint Neuro vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ClearPoint Neuro with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
ClearPoint Neuro	Buy	$282.2M	-47.41%	-7.84	62.61%	0.00%
Medtronic	Buy	$121.0B	-21.53%	22.75	66.69%	3.07%
Edwards Lifesciences	Buy	$51.0B	-22.73%	50.80	77.98%	0.00%
Stryker	StrongBuy	$116.8B	11.37%	30.59	65.17%	1.18%
Abbott Laboratories	StrongBuy	$173.9B	-19.11%	32.34	56.80%	2.51%

See all

Stock Returns calculator for ClearPoint Neuro Stock including INR - Dollar returns

The ClearPoint Neuro stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

ClearPoint Neuro investment value today

Current value as on today

₹38,992

Returns

-₹61,008

(-61.01%)

Returns from ClearPoint Neuro Stock

-₹63,949 (-63.95%)

Dollar Impact

₹2,941 (+2.94%)

Analyst Recommendation on ClearPoint Neuro Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for ClearPoint Neuro. Average target price of $23.5

ClearPoint Neuro Share Price Target

Get share price movements and forecasts by analysts on ClearPoint Neuro.

What analysts predicted

61.23%UPSIDE

Target Price

$23.5

Current Price

$9.11

Analyzed by

1 Analysts

Target

$23.50

ClearPoint Neuro target price $23.5, a slight upside of 61.23% compared to current price of $9.11. According to 1 analysts rating.

Indian Investors' Interest in ClearPoint Neuro Stock

Investment in ClearPoint Neuro Shares on INDmoney has grown by 88.19% in the last 30 days, indicating increased investment activity.

Time period: September 24, 2026 to October 24, 2026

Change:88.19% versus previous 30 day period

Search interest for ClearPoint Neuro Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 24, 2026 to October 24, 2026

Change:42% versus previous 30 day period

ClearPoint Neuro Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	7	7	8	7	8	9	8	10	12	10
Gross Profit	4	4	4	4	5	5	5	6	7	6
Operating Income	-4	-4	-5	-5	-6	-5	-5	-7	-8	-10
EBITDA	-3	-3	-4	-4	-5	-5	-4	-6	-7	-8
Interest Expense	-	-	-	-	-	0	0	0	1	1
Depreciation	0	0	0	0	0	0	0	0	1	1
Income Before Tax	-4	-4	-4	-5	-6	-5	-5	-7	-9	-11
Income Tax Expense	-	-	-	-	0	0	0	0	0	0
Net Income	-4	-4	-4	-5	-6	-5	-5	-7	-9	-11
Net Profit Margin	59.24%	63.48%	59.68%	61.28%	60.48%	60.29%	63.20%	61.52%	62.24%	63.58%

ClearPoint Neuro Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	7	7	11	12	16	20	23	31	36
Gross Profit	4	4	7	9	11	13	13	19	22
Operating Income	-6	-5	-4	-6	-13	-16	-22	-19	-24
EBITDA	-6	-5	-4	-4	-12	-15	-20	-17	-20
Interest Expense	0	0	0	1	0	0	-	-	2
Depreciation	0	0	0	0	0	0	1	1	2
Income Before Tax	-7	-6	-5	-6	-14	-16	-22	-18	-25
Income Tax Expense	-	-	-	-	-	-	-	-	0
Net Income	-7	-6	-5	-6	-14	-16	-22	-18	-25
Net Profit Margin	60.72%	66.91%	64.86%	71.09%	68.24%	65.84%	56.83%	60.92%	61.38%

ClearPoint Neuro Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-4	-4	-4	-5	-6	-5	-5	-7	-9	-11
Operating Cash Flow	-3	-2	-1	-1	-6	-2	-3	-12	-7	-7
Investing Cash Flow	-	-	0	0	0	0	0	1	0	0
Financing Cash Flow	16	0	-10	0	-1	31	-	19	-1	1
Change in Cash	12	-2	-11	-1	-7	29	-3	8	-10	-6

ClearPoint Neuro Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-7	-6	-5	-6	-14	-16	-22	-18	-25
Operating Cash Flow	-5	-4	-2	-7	-12	-16	-13	-8	-23
Investing Cash Flow	0	0	0	0	0	-10	8	0	0
Financing Cash Flow	11	-1	5	22	46	0	0	6	50
Change in Cash	5	-6	2	14	34	-26	-4	-3	26

Global Institutional Holdings in ClearPoint Neuro

Check out the Institutions with significant holdings in ClearPoint Neuro.

Funds	Holdings
Vanguard	4.59%
VANGUARD INDEX FUNDS	3.98%
iShares	3.61%
SPDR	1.09%
Fidelity Salem Street Trust	0.98%

See all

Insights on ClearPoint Neuro

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CLPT has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 17.7% return, outperforming this stock by 81.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 12.12M → 10.88M (in $), with an average decrease of 10.3% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, CLPT stock has moved down by -38.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 5 quarters, -5.83M → -11.33M (in $), with an average decrease of 18.6% per quarter

About ClearPoint Neuro

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.

Organisation	ClearPoint Neuro
Headquarters	120 S. Sierra Avenue, Solana Beach, CA, 92075, US
Industry	Medical - Devices
CEO	Joseph Michael Burnett

Key Management of ClearPoint Neuro

Name	Title
Mr. Jeremy L. Stigall	Chief Business Officer
Mr. Mazin Sabra	Chief Operating Officer
Mr. Robert C. Korn	Senior Vice President of Sales & Business Development
Dr. Paul S. Larson FAANS, M.D.	Chief Medical Officer
Ms. Mary McNamara-Cullinane RAC	Senior Vice President of Regulatory Affairs
Ms. Megan Faulkenberry	Senior Vice President of Quality
Mr. Joseph Michael Burnett	President, CEO & Director
Mr. Danilo D'Alessandro	Chief Financial Officer

FAQs

What is ClearPoint Neuro share price today?

ClearPoint Neuro share price today is $9.11 as on October 24, 2026 at 12:54 am IST. ClearPoint Neuro share today touched a day high of $9.14 and a low of $8.95.

What is the 52 week high and 52 week low for ClearPoint Neuro share?

ClearPoint Neuro share touched a 52 week high of $27.27 on October 28, 2025 and a 52 week low of $8.27 on April 10, 2026. ClearPoint Neuro stock price today i.e. October 24, 2026 at 12:54 am IST is trending at $9.11,which is 66.59% down from its 52 week high and 10.16% up from its 52 week low.

What is ClearPoint Neuro's market capitalisation today?

ClearPoint Neuro market capitalisation is $0.00T as on October 24, 2026 at 12:54 am IST.

How to invest in ClearPoint Neuro Stock (CLPT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for ClearPoint Neuro on INDmoney app. Click on Buy button.

What is the minimum amount required to buy ClearPoint Neuro Stock (CLPT) from India?

Indian investors can start investing in ClearPoint Neuro (CLPT) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 12:54 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in ClearPoint Neuro stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 12:54 am IST). Based on ClearPoint Neuro share’s latest price of $9.11 as on October 24, 2026 at 12:54 am IST, you will get 1.0977 shares of ClearPoint Neuro. Learn more about fractional shares .

What are the returns that ClearPoint Neuro has given to Indian investors in the last 5 years?

ClearPoint Neuro stock has given -47.41% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?